Skip to content

Radiographic Evaluation Of Newly Formed Bone Tissue In Extraction Sockets After Systemic Antibiotic Administration

Radiographic Evaluation Of Newly Formed Bone Tissue In Extraction Sockets After Systemic Antibiotic Administration

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250526003
Enrollment
60
Registered
2025-05-26
Start date
2025-05-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of systemic antibiotics on new bone formation after tooth extraction. Bone formation, Systemic antibiotic

Interventions

Patients who received 2 g IV ampicillin prior to mandibular molar extraction
30 minutes later, venous blood was drawn to prepare A-PRF, which was placed into the extraction socket, and the socket was approximated/closed with 3-0 silk sutures.,Patients who received 600 mg IM cl
30 minutes later, venous blood was drawn to prepare A-PRF, which was applied to the extraction socket, and the socket was approximated/closed with 3-0 silk sutures. (These patients had a penicillin al
the socket was irrigated with sterile normal saline only and approximated/closed with 3-0 silk sutures. No PRF was used, and no prophylactic/systemic antibiotics were administered.
Group 1,Group 2,Group 3(Control)

Sponsors

Faculty of Dentistry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 60 years. Patients classified as ASA I or ASA II. Patients with an extraction indication for at least one mandibular molar. Patients receiving prophylactic antibiotic therapy (ampicillin 2 g IV or clindamycin 600 mg IM). Patients with no history of long-term opioid use. Patients without current intraoral infection (e.g., abscess, cellulitis), acute pericoronitis, or osteomyelitis. Patients with no history of antiresorptive/anti-angiogenic therapy (e.g., bisphosphonates, denosumab). Patients with no current smoking or alcohol use.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years or older than 60 years. Patients with a history of long-term opioid use. Patients with current intraoral infection (e.g., abscess, cellulitis), acute pericoronitis, or osteomyelitis. Patients with a history of antiresorptive/anti-angiogenic therapy (e.g., bisphosphonates, denosumab). Patients with active smoking or alcohol use. Patients receiving anticoagulant therapy (e.g., warfarin [Coumadin]). Pregnant or lactating patients. Patients with incomplete examination and control records.

Design outcomes

Primary

MeasureTime frame
bone density postoperative 1 months panaromic radiograph( Fractal Analysis)

Secondary

MeasureTime frame
bone trabecular pattern postoperative 1 months panaromic radiograph( Fractal Analysis)

Countries

Turkey

Contacts

Public ContactCennet Eroglu

Akdeniz University

neslihanakca2003@yahoo.com05326084485

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026